Sign In
Buy DIOD
$116.22
+2.09 (+1.83%)
At Close: Jun 03, 2026
FOREX-Yen rises on renewed surge in virus cases; dollar index falls
03:18pm, Friday, 10'th Jul 2020
* U.S. producer prices fall in June, dollar weaker * U.S. COVID cases post one-day record on Thursday * Yuan dips but stays near 4-month high * Graphic: World FX rates in 2020 https://tmsnrt.rs/2RB
Gilead Says New Analysis Suggests Remdesivir Reduces Covid-19 Deaths
02:16pm, Friday, 10'th Jul 2020
Gilead cautioned that the finding —a 62% reduction in Covid-19 deaths—needed to be confirmed in clinical trials. An earlier study of remdesivir found that the drug shortened the duration of a Covi
Oil Gets Rare, Late Week Boost From IEA Demand Outlook
02:14pm, Friday, 10'th Jul 2020
The global energy agency that rarely helps the positive case in oil has given a friendly boost to those long crude, just as the week comes to an end. Crude prices jumped more than 1% on Friday after
Oil Rebounds on Dollar Weakness Yet Demand Woes Linger
02:03pm, Friday, 10'th Jul 2020
(Bloomberg) -- Crude reversed losses amid a weaker U.S. currency, easing a decline this week that’s been led by a gloomy demand outlook with virus cases surging. Oil rose 0.9% in New York on Friday.
Gildead: Remdesivir reduces deaths in COVID-19 patients
01:52pm, Friday, 10'th Jul 2020
Yahoo Finance’s Alexis Christoforous and Brian Sozzi discuss the latest coronavirus news with Yahoo Medical Contributor and Columbia University Associate Professor of Emergency Medicine, Dr. Dara Ka
How Did Gilead Sciences, Inc.'s (NASDAQ:GILD) 22% ROE Fare Against The Industry?
01:41pm, Friday, 10'th Jul 2020
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Dow and broader stock-market futures turn positive amid upbeat report on Gilead's experimental coronavirus treatment
01:10pm, Friday, 10'th Jul 2020
U.S. stock-index futures turned positive on Friday after a report from Gilead Sciences indicated that its experimental treatment for coronavirus was seeing positive results in reducing deaths. Futures
A new Gilead analysis indicates remdesivir can reduce death but company says finding 'requires confirmation'
01:07pm, Friday, 10'th Jul 2020
Shares of Gilead Sciences Inc. gained 2.0% in premarket trading on Friday after the drugmaker disclosed findings from a new analysis of previously disclosed clinical trial data that found the experim
Gilead says additional data on remdesivir shows improved clinical recovery
12:45pm, Friday, 10'th Jul 2020Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19
12:30pm, Friday, 10'th Jul 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, adding to the available body of knowledge on treatment o
Australia approves Gilead's remdesivir for COVID-19 treatment
12:26pm, Friday, 10'th Jul 2020
Australia has granted provisional approval to Gilead Sciences Inc's remdesivir as the first treatment option for COVID-19 in the country, the Therapeutic Goods Administration (TGA) said on Friday. Th
Gilead to deliver more remdesivir to Germany, Europe from the Fall - WiWo
07:18am, Thursday, 09'th Jul 2020
Gilead Sciences Inc plans to make more of its drug remdesivir available for Germany and Europe from the Fall and will decide how much each country gets based on the rate of infection, the drugmaker's
Coronavirus latest: Wednesday, July 8
07:32pm, Wednesday, 08'th Jul 2020
Cases of coronavirus continue to rise in the United States, with states breaking daily records and no clear insight into how to curve the outbreak. Yahoo Finance’s Anjalee Khemlani breaks down the l
CORRECTED-Gilead begins testing inhalable form of remdesivir for COVID-19
06:50pm, Wednesday, 08'th Jul 2020Gilead's stock drops as it starts early-stage trial for inhaled remdesivir
06:49pm, Wednesday, 08'th Jul 2020
Shares of Gilead Sciences Inc. fell 1.4% in trading on Wednesday after the drugmaker said it started a Phase 1a clinical study testing an inhaled version of its experimental COVID-19 drug remdesivir.
